Zoll Medical Corporation
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Zoll Medical Corporation sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).
Zoll Medical Corporation: 24 sponsored US clinical trials, 2 recruiting.
Zoll Medical Corporation sponsors 24 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 18 completed. The most-studied condition in this pipeline is Heart Failure, with 2 trials.
Top-decile sponsor footprint
Zoll Medical Corporation ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
18 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
24 total, page 1 of 1
Janus II Feasibility
NCT06556693
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
NCT04504188
AED 3 Post-Approval Study
NCT05013333
Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in PatientS Wearing a Novel Device With Biometric Based Medications Changes
NCT05505136
Rapid Treatment of Shock Without Trauma
NCT05073354
Mobile Cardiac Telemetry and Advanced Multi-Parameter Monitoring in Patients
NCT04754204
Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator
NCT04292405
Benefits of Microcor in Ambulatory Decompensated Heart Failure
NCT04096040
RapidShock Post-Approval Study
NCT04014842
Benefits of µCor in Ambulatory Decompensated Heart Failure
NCT03476187
Heart Sounds Registry
NCT03203629
Heart Failure Optimization Study
NCT03016754
FiO2 Closed Loop Control Ventilation
NCT02810080
Measuring Thoracic Impedance in Hemodialysis Patients With the u-Cor Monitoring System
NCT03072732
Verification of Prediction Algorithm
NCT02863666
Heart Sounds Measurement Using the Wearable Cardioverter Defibrillator (HS-WCD) Study
NCT02825966
Wearable Cardioverter Defibrillator in Hemodialysis Patients (WED-HED) Study
NCT02481206
Ambulatory Post-Syncope Arrhythmia Protection Feasibility Study
NCT02188147
LifeVest Wearable Cardioverter Defibrillator WEARIT-III Registry
NCT02700880
Hospital Wearable Defibrillator Inpatient Study
NCT02122549
LifeVest Trends Validation Protocol
NCT02149290
Study of the Wearable Defibrillator in Heart-Failure Patients
NCT01326624
LifeVest Post-CABG Registry
NCT01448005
Circulation Improving Resuscitation Care (CIRC)
NCT00597207
What is open in the Zoll Medical Corporation pipeline
2 recruiting of 24 indexed (8% open); 18 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Heart Failure (2 trials), 7 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Zoll Medical Corporation: open-pipeline peers nationwide
Peers matched on 24 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
Zoll Medical Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 24 trials (± recruiting share)
- Acrotech Biopharma · 24 trials · 8% recruiting
- Agenus · 24 trials · 0% recruiting
- Akebia Therapeutics · 24 trials · 4% recruiting
- Blueprint Medicines Corporation · 24 trials · 25% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Atlanta VA Medical Center · 8% recruiting · 12 trials
- Beacon Therapeutics · 8% recruiting · 12 trials
- Boston VA Research Institute · 8% recruiting · 12 trials
- Centrexion Therapeutics · 8% recruiting · 12 trials
Related
What to do with this Zoll Medical Corporation page
24 registered trials is a research-attention snapshot, not an endorsement of Zoll Medical Corporation or any single study.
- 2 of Zoll Medical Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure is the condition Zoll Medical Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Zoll Medical Corporation pipeline card: 24 registered trials from official public datasets.Report a data error.